Jabs from Johnson & Johnson were central to plans to scale up South Africa’s COVID-19 vaccination programme. With news that a first consignment of two million doses cannot be used, it is critical that government play open cards with the public about its revised vaccination plans and timelines and what steps it is taking to procure more vaccines faster.
Government has been criticised for the slow pace of the country’s vaccine rollout which started on 17 May 2021. Elri Voigt spoke to experts to hear what is being done right in this vaccine rollout and where improvements are needed.
While it is uncertain when teachers in the Free State will receive vaccinations during this third wave, the number of COVID-19 infections and deaths in the province’s schools continues to increase. Refilwe Mochoari reports.
Before any COVID-19 vaccines can be made available in South Africa, they must be authorised by South Africa’s medicines regulator—the South African Health Products Regulatory Authority (SAHPRA). Catherine Tomlinson explores how SAHPRA is preparing to review and authorise the use of COVID-19 vaccines in the country and the different authorisation approaches they may use.
Two years after it was announced that the ARV dolutegravir would become part of standard first line HIV treatment in South Africa, it is finally reaching significant numbers of people. But new research about a worrying side-effect, weight gain (particularly in women), has muddied its otherwise stellar reputation.